bibliographicCitation |
Walenga JM, Prechel M, Jeske WP, Hoppensteadt D, Maddineni J, Iqbal O, Messmore HL, Bakhos M. Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia. Br J Haematol. 2008 Oct;143(1):92–9. doi: 10.1111/j.1365-2141.2008.07300.x. PMID: 18671707. |